Effects of RPR 118723, a novel antagonist at the glycine site of the NMDA receptor, in vitro (original) (raw)

Abstract

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (24)

  1. Bigge, C.F., 1993. Structural requirement for the development of potent Ž .
  2. N-methyl-D-aspartic acid NMDA receptor antagonists. Biochem. Pharmacol. 45, 1547-1561.
  3. Boireau, A., Miquet, J.M., Olivier, V., 1993. Neurotensin modulates differently potassium, veratridine and 4-aminopyridine-evoked release of dopamine in rat striatal slices. Fundam. Clin. Pharmacol. 7, 109-114.
  4. Boireau, A., Malgouris, C., Burgevin, M.C., Peny, C., Durand, G., Bordier, F., Meunier, M., Miquet, J.M., Daniel, M., Chevet, T., Jimonet, P., Mignani, S., Blanchard, J.C., Doble, A., 1996. Neuropro- tective effects of RPR 104632, a novel antagonist at the glycine site of the NMDA receptor, in vitro. Eur. J. Pharmacol. 300, 237-246.
  5. Carter, A.J., 1992. Glycine antagonists: regulation of the NMDA recep- tor-channel complex by the strychnine-insensitive glycine site. Drugs Future 17, 595-613.
  6. Grimwood, S., Kulagowski, J.J., Mawer, I.M., Rowley, M., Leeson, P.D., Foster, A.C., 1995. Allosteric modulation of the glutamate site on the NMDA receptor by four novel glycine site antagonists. Eur. J. Pharmacol. 290, 221-226.
  7. Hanbauer, I., Wink, D., Osawa, Y., Edelman, G.M., Gally, J.A., 1992. w 3 x Role of nitric oxide in NMDA-evoked release of H -dopamine from striatal slices. NeuroReport 3, 409-412.
  8. Hori, T., Yamamoto, T., Hatta, K., Moroji, T., 1991. Modulation of 2q w 3 x Mg -dependent H TCP binding by L-glutamate, glycine, and gua- nine nucleotides in rat cerebral cortex. Synapse 8, 13-21.
  9. Ilyin, V.I., Whittemore, E.R., Tran, M., Shen, K.-Z., Cai, S.-X., Kher, S.M., Keana, J.F.W., Weber, E., Woodward, R.M., 1996. Pharmacol- ogy of ACEA-1416: a potent systemically active NMDA receptor glycine antagonist. Eur. J. Pharmacol. 310, 107-114.
  10. Jimonet, P., Ribeill, Y., Bohme, A., Boireau, A., Cheve, M., Damour, D., ¨Doble, A., Genevois-Borella, A., Hermann, F., Imperato, A., Le Guern, S., Manfre, F., Pratt, J., Randle, J.C.R., Stutzmann, J.M., ´w x
  11. Mignani, S., 2000. Indeno 1,2-b pyrazin-2,3-diones : a new class of antagonists at the glycine site of the NMDA receptor with potent in vivo activity. J. Med. Chem. 43, 2371-2381.
  12. Johnson, J.W., Ascher, P., 1987. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325, 529-531.
  13. Kehne, J.H., Baron, B.M., Harrison, B.L., McCloskey, T.C., Palfreyman, M.G., Poirot, M., Salituro, F.G., Siegel, B.W., Slone, A.L., Van Giersbergen, P.L.M., White, H.S., 1995. MDL 100,458 and MDL 102,288: two potent and selective glycine receptor antagonists with different functional profiles. Eur. J. Pharmacol. 284, 109-118.
  14. Kemp, J.A., Leeson, P.D., 1993. The glycine site of the NMDA receptor -five years on. Trends Pharmacol. Sci. 14, 20-25.
  15. Kloog, Y., Lamdani-Itkin, H., Sokolovsky, M., 1990. The glycine site of the N-methyl-D-aspartate receptor channel: differences between the binding of HA-966 and of 7-chlorokynurenic acid. J. Neurochem. 54, 1576-1583.
  16. Krebs, M.O., Desce, J.M., Kemel, M.L., Gauchy, C., Godeheu, G., Cheramy, A., Glowinski, J., 1991. Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D- aspartate receptors on dopaminergic nerve terminals. J. Neurochem. 56, 81-85.
  17. Kulagowski, J.J., Leeson, P.D., 1995. Glycine-site NMDA receptor an- tagonists. Exp. Opin. Ther. Patents 5, 1061-1075.
  18. Mignani, S., Aloup, J.-C., Barreau, M., Birraux, G., Blanchard, J.-C., Bohme, A., Boireau, A., Damour, D., Doble, A., Jimonet, P., Malgo- uris, C., Mary, V., Randle, J.C.R., Rataud, J., Stutzmann, J.-M., 1995. 2H-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxylic acid derivatives, a novel family of glycine antagonists of the NMDA channel complex. Drugs Future 11, 1133-1143.
  19. Nankai, M., Fage, D., Carter, C., 1995. Striatal NMDA subtypes: the pharmacology of N-methyl-D-aspartate-evoked dopamine, g-amino- ( )
  20. A. Boireau et al.r European Journal of Pharmacology 401 2000 131-135 135
  21. butyric acid, acetylcholine and spermidine release. Eur. J. Pharmacol. 286, 61-70.
  22. Ornstein, P.L., Monn, J.A., Schoepp, D.D., 1994. Antagonists of the NMDA receptor complex. Drug News Perspect. 7, 5-12.
  23. Werling, L.L., Jacocks, H.M. III, McMahon, P.N., 1990. Regulation of w 3 x H dopamine release from guinea pig striatum by NMDA receptorrchannel activators and inhibitors. J. Pharmacol. Exp. Ther. 255, 40-45.
  24. Wood, P.L., Hawkinson, J.E., 1997. N-methyl-D-aspartate antagonists for stroke and head trauma. Exp. Opin. Invest. Drugs 6, 389-397.